Of note, despite high anti-melanoma efficacy, the combination of ZD55-IL-24 and PD-1 blockade was associated with no significant systemic toxicity, as mice did not show significant weight or hair loss (Fig. 1e). This evidence concerns the gene PDCD1 and melanoma.